Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrosing Interstitial Lung Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03858842
What this trial is testing

Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017

Who this might be right for
Lung Diseases, InterstitialLung Disease With Systemic Sclerosis
Hospices Civils de Lyon 100
Not applicableNo Longer AvailableNCT04739150
What this trial is testing

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim
Large-scale testing (Phase 3)Looking for participantsNCT07540988
What this trial is testing

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Who this might be right for
Interstitial Lung Diseases
Boehringer Ingelheim 466
Not applicableLooking for participantsNCT07004595
What this trial is testing

Evaluation of Frailty in Patients With Fibrosing Interstitial Lung Diseases: Prognostic and Therapeutic Impact

Who this might be right for
Sarcopenia
Nantes University Hospital 100
Large-scale testing (Phase 3)Study completedNCT02999178
What this trial is testing

Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 663
Not applicableUnknownNCT00518310
What this trial is testing

Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Thorax National Institute 100
Large-scale testing (Phase 3)Study completedNCT04093024
What this trial is testing

Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 39
Not applicableStudy completedNCT05855447
What this trial is testing

Muscles Oxygenation During Exercise in Fibrosing Interstitial Lung Diseases

Who this might be right for
Lung Diseases, InterstitialExercise, CompulsiveOxygen Deficiency
Saglik Bilimleri Universitesi 36
Early research (Phase 1)UnknownNCT04537130
What this trial is testing

Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge

Who this might be right for
Pulmonary FibrosisCovid19
Instituto Oncológico Dr Rosell 40
Large-scale testing (Phase 3)WithdrawnNCT05067517
What this trial is testing

Efficacy & Safety of Nintedanib in Patients With Progressive Fibrosing Coal Mine Dust-Induced Interstitial Lung Disease

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease
West Virginia University
Large-scale testing (Phase 3)Study completedNCT00070590
What this trial is testing

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Who this might be right for
Pulmonary FibrosisScleroderma, Systemic
Actelion 132
Not applicableLooking for participantsNCT07457502
What this trial is testing

Domestic Environmental Exposure and Progression of ILD: An Exploratory Case-Control Study

Who this might be right for
Assess PID Diagnosis Revision After CMEI AuditAssess CMEI Recommendations' Impact on Respiratory HealthILD Progression and Exposure to Indoor Environnemental Risk+1 more
Ville de Paris 100
Not applicableUnknownNCT05455437
What this trial is testing

Monitoring and Evaluation Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Diseases
Pulmonary Care and Research Collaborative Limited 200
Early research (Phase 1)UnknownNCT00129350
What this trial is testing

Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation

Who this might be right for
EmphysemaAlveolitis, FibrosingCystic Fibrosis+2 more
Royal Brompton & Harefield NHS Foundation Trust 60
Not applicableStudy completedNCT03979703
What this trial is testing

Yoga in Patients With Fibrosing Interstitial Lung Diseases

Who this might be right for
Fibrosing Interstitial Lung DiseasesIdiopathic Pulmonary Fibrosis
Heidelberg University 17
Early research (Phase 1)Study completedNCT00563212
What this trial is testing

A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
NYU Langone Health 12
Not applicableEnrolling By InvitationNCT06844331
What this trial is testing

Ultrasound Applicability in the Assessment of Patients With Fibrosing Interstitial Lung Disease

Who this might be right for
Fibrosing Interstitial Lung DiseasesThoracic Ultrasound
Odense University Hospital 117
Large-scale testing (Phase 3)Looking for participantsNCT06440746
What this trial is testing

Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases

Who this might be right for
Lung Diseases, Interstitial
R-Pharm International, LLC 138
Not applicableStudy completedNCT05151640
What this trial is testing

INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 158
Not applicableLooking for participantsNCT06855004
What this trial is testing

Prospective Cohort of Patients With Fibrosing Interstitial Lung Disease Admitted for Acute Respiratory Failure

Who this might be right for
Fibrosing Interstitial Lung Disease
Assistance Publique - Hôpitaux de Paris 250
Next Page